Exact Mass: 331.0820848

Exact Mass Matches: 331.0820848

Found 53 metabolites which its exact mass value is equals to given mass value 331.0820848, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

malvidin

3 4 5 7-tetrahydroxy-3 5-dimethoxyflavylium chloride

[C17H15O7]+ (331.081774)


   

zotepine

zotepine

C18H18ClNOS (331.07975680000004)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics Zotepine, an antipsychotic agent, is a potent antagonist of 5-HT2A, 5-HT2C, Histamine H1, α1-adrenergic and Dopamine D2 receptors, with Kds of 2.6 nM, 3.2 nM, 3.3 nM, 7.3 nM and 8 nM, respectively. Zotepine exhibits antidepressive and anxiolytic effects in vivo[1][2].

   

7-Chloro-N-[3-(2-nitroimidazol-1-yl)propyl]quinolin-4-amine

7-chloro-N-[3-(2-nitro-1H-imidazol-1-yl)propyl]quinolin-4-amine

C15H14ClN5O2 (331.0835974)


   

Chlorprothixene sulfoxide

2-chloro-9-[3-(dimethylamino)propylidene]-9H-10lambda4-thioxanthen-10-one

C18H18ClNOS (331.07975680000004)


   

Didesethylflurazepam

1-(2-aminoethyl)-7-chloro-5-(2-fluorophenyl)-2,3-dihydro-1H-1,4-benzodiazepin-2-one

C17H15ClFN3O (331.0887622)


   

(2S,3S)-2-(2,4-Difluorophenyl)-3-methylsulfonyl-1-(1,2,4-triazol-1-yl)butan-2-ol

Threo-2-(2,4-difluorophenyl)-3-methylsulfonyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

C13H15F2N3O3S (331.08021440000005)


   

Ggstop

2-Amino-4-((3-(carboxymethyl)phenyl)(methyl)phosphono)butanoic acid

C13H18NO7P (331.0820848)


   

Dibenz(b,f)(1,4)oxazepine-10(11H)-carboxylic acid, 8-chloro-, 2-acetylhydrazide

13-Chloro-N-(1-hydroxyethylidene)-2-oxa-9-azatricyclo[9.4.0.0,]pentadeca-1(15),3,5,7,11,13-hexaene-9-carbohydrazonate

C16H14ClN3O3 (331.07236439999997)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D011448 - Prostaglandin Antagonists

   

N'-Acetyl-3-chloro-6H-benzo[b][1,4]benzoxazepine-5-carbohydrazide

6-Chloro-N-(1-hydroxyethylidene)-2-oxa-9-azatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaene-9-carbohydrazonate

C16H14ClN3O3 (331.07236439999997)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D011448 - Prostaglandin Antagonists

   

zotepine

[2-({6-chloro-2-thiatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3,5,7,9,11,13-heptaen-9-yl}oxy)ethyl]dimethylamine

C18H18ClNOS (331.07975680000004)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics Zotepine, an antipsychotic agent, is a potent antagonist of 5-HT2A, 5-HT2C, Histamine H1, α1-adrenergic and Dopamine D2 receptors, with Kds of 2.6 nM, 3.2 nM, 3.3 nM, 7.3 nM and 8 nM, respectively. Zotepine exhibits antidepressive and anxiolytic effects in vivo[1][2].

   
   

Europinidin

3,7,3,4-Tetrahydroxy-5,5-dimethoxyflavylium

C17H15O7 (331.081774)


   

O1-[(3,5-Dimethylisoxazol-4-yl)carbonyl]-2-[3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanehydroximamide

O1-[(3,5-Dimethylisoxazol-4-yl)carbonyl]-2-[3-(trifluoromethyl)-1H-pyrazol-1-yl]ethanehydroximamide

C12H12F3N5O3 (331.0892198)


   

MY-5445

1-Phthalazinamine, N-(3-chlorophenyl)-4-phenyl-

C20H14ClN3 (331.08761940000005)


MY-5445 is a specific inhibitor of the cyclic GMP phosphodiesterase, phosphodiesterase type 5 (PDE5), with a Ki of 1.3 μM. MY-5445 inhibits human platelet aggregation. MY-5445 is a selective modulator of ATP-binding cassette (ABC) transporter ABCG2, with anti-proliferative effect[1][2].

   
   

SC-19220

8-chloro-dibenz[b,f][1,4]oxazepine-10(11H)-carboxy-(2-acetyl)hydrazide

C16H14ClN3O3 (331.07236439999997)


   

malvidin

malvidin

C17H15O7+ (331.081774)


An anthocyanidin cation that is delphinidin carrying methyl substituents at positions 3 and 5.

   

7-chloro-4-(4-methylpiperazin-1-yl)-10H-thieno[3,2-c][1]benzazepine

7-chloro-4-(4-methylpiperazin-1-yl)-10H-thieno[3,2-c][1]benzazepine

C17H18ClN3S (331.09098980000005)


   
   

4-chlorophenyl-2-acetamido-2-deoxy-beta-d-glucopyranoside

4-chlorophenyl-2-acetamido-2-deoxy-beta-d-glucopyranoside

C14H18ClNO6 (331.0822598)


   

4-[2-[[(4-Methylphenyl)sulfonyl]oxy]ethyl]-1,3-dihydro-2H-indole-2-one

4-[2-[[(4-Methylphenyl)sulfonyl]oxy]ethyl]-1,3-dihydro-2H-indole-2-one

C17H17NO4S (331.08782420000006)


   
   

4-(ISOCYANO(TOSYL)METHYL)-1,2-DIMETHOXYBENZENE

4-(ISOCYANO(TOSYL)METHYL)-1,2-DIMETHOXYBENZENE

C17H17NO4S (331.08782420000006)


   

L-Phenylalanine,N-(2,4-dinitrophenyl)-

L-Phenylalanine,N-(2,4-dinitrophenyl)-

C15H13N3O6 (331.08043180000004)


   

1-amino-4-hydroxy-2-phenoxyanthraquinone

1-amino-4-hydroxy-2-phenoxyanthraquinone

C20H13NO4 (331.08445380000006)


   

tert-butyl 4-(2,6-dichloropyridin-4-yl)piperazine-1-carboxylate

tert-butyl 4-(2,6-dichloropyridin-4-yl)piperazine-1-carboxylate

C14H19Cl2N3O2 (331.0854254)


   

(+-)-Benzyloxycarbonyl-alpha-phosphonoglycinetrimethylester

(+-)-Benzyloxycarbonyl-alpha-phosphonoglycinetrimethylester

C13H18NO7P (331.0820848)


   

2-METHYL-5-PHENYL-3-(3-SULFOPROPYL)BENZOXAZOLIUM HYDROXIDE, INNER SALT

2-METHYL-5-PHENYL-3-(3-SULFOPROPYL)BENZOXAZOLIUM HYDROXIDE, INNER SALT

C17H17NO4S (331.08782420000006)


   

4-{5-[(2-Chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid hydrochloride (1:1)

4-{5-[(2-Chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoic acid hydrochloride (1:1)

C14H19Cl2N3O2 (331.0854254)


   
   
   
   

Glypinamide

Glypinamide

C13H18ClN3O3S (331.0757348)


C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C97936 - Sulfonylurea Antidiabetic Agent

   

N-[[2-(1-pyrrolidinyl)anilino]-sulfanylidenemethyl]-2-thiophenecarboxamide

N-[[2-(1-pyrrolidinyl)anilino]-sulfanylidenemethyl]-2-thiophenecarboxamide

C16H17N3OS2 (331.0812992)


   

4-amino-6,7-diphenyl-2(1H)-pteridinethione

4-amino-6,7-diphenyl-2(1H)-pteridinethione

C18H13N5S (331.08916180000006)


   

(E)-3-(3-(N-(2-hydroxyethyl)sulfamoyl)-4,5-dimethoxyphenyl)acrylic acid

(E)-3-(3-(N-(2-hydroxyethyl)sulfamoyl)-4,5-dimethoxyphenyl)acrylic acid

C13H17NO7S (331.07256920000003)


   

2-[(Phenylsulfonyl)amino]-5,6,7,8-tetrahydronaphthalene-1-carboxylic acid

2-[(Phenylsulfonyl)amino]-5,6,7,8-tetrahydronaphthalene-1-carboxylic acid

C17H17NO4S (331.08782420000006)


   

4-{(Z)-[2-[3-(Methylsulfanyl)Propanoyl]-5-Oxo-1-(2-Oxoethyl)-1,5-Dihydro-4h-Imidazol-4-Ylidene]Methyl}Benzenolate

4-{(Z)-[2-[3-(Methylsulfanyl)Propanoyl]-5-Oxo-1-(2-Oxoethyl)-1,5-Dihydro-4h-Imidazol-4-Ylidene]Methyl}Benzenolate

C16H15N2O4S- (331.07524900000004)


   

(2S,3S)-2-(2,4-Difluorophenyl)-3-methylsulfonyl-1-(1,2,4-triazol-1-yl)butan-2-ol

Threo-2-(2,4-difluorophenyl)-3-methylsulfonyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

C13H15F2N3O3S (331.08021440000005)


D000890 - Anti-Infective Agents > D000935 - Antifungal Agents

   

Sulochrin(1-)

Sulochrin(1-)

C17H15O7- (331.081774)


A phenolate anion that is the conjugate base of sulochrin, obtained by deprotonation of one of the phenolic hydroxy groups; major species at pH 7.3.

   

5-(3-chlorophenyl)-N-(2-propyl-5-tetrazolyl)-2-furancarboxamide

5-(3-chlorophenyl)-N-(2-propyl-5-tetrazolyl)-2-furancarboxamide

C15H14ClN5O2 (331.0835974)


   

2-Ethoxy-3-pyridinecarboxylic acid (6-chloro-2-imidazo[1,2-a]pyridinyl)methyl ester

2-Ethoxy-3-pyridinecarboxylic acid (6-chloro-2-imidazo[1,2-a]pyridinyl)methyl ester

C16H14ClN3O3 (331.07236439999997)


   

(9Z)-7-chloro-9-[3-(dimethylamino)propylidene]thioxanthen-2-ol

(9Z)-7-chloro-9-[3-(dimethylamino)propylidene]thioxanthen-2-ol

C18H18ClNOS (331.07975680000004)


   

6-{Hydroxy[(4-nitrobenzyl)oxy]phosphoryl}hexanoic acid

6-{Hydroxy[(4-nitrobenzyl)oxy]phosphoryl}hexanoic acid

C13H18NO7P (331.0820848)


   

4-[(5Z)-5-[(Z)-2-methyl-3-phenylprop-2-enylidene]-2,4-dioxo-1,3-thiazolidin-3-yl]butanoic acid

4-[(5Z)-5-[(Z)-2-methyl-3-phenylprop-2-enylidene]-2,4-dioxo-1,3-thiazolidin-3-yl]butanoic acid

C17H17NO4S (331.08782420000006)


   

(3Z)-3-[(10S)-2-chloro-10-oxothioxanthen-9-ylidene]-N,N-dimethylpropan-1-amine

(3Z)-3-[(10S)-2-chloro-10-oxothioxanthen-9-ylidene]-N,N-dimethylpropan-1-amine

C18H18ClNOS (331.07975680000004)


   

(9E)-7-chloro-9-[3-(dimethylamino)propylidene]thioxanthen-1-ol

(9E)-7-chloro-9-[3-(dimethylamino)propylidene]thioxanthen-1-ol

C18H18ClNOS (331.07975680000004)


   

Didesethylflurazepam

Didesethylflurazepam

C17H15ClFN3O (331.0887622)


A primary amino compound resulting from the dealkylation of both ethyl groups of the anti-insomnia drug flurazepam. It is the major metabolite of flurazepam.

   

N-Acetyl-3-chloro-6H-benzo[b][1,4]benzoxazepine-5-carbohydrazide

N-Acetyl-3-chloro-6H-benzo[b][1,4]benzoxazepine-5-carbohydrazide

C16H14ClN3O3 (331.07236439999997)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D011448 - Prostaglandin Antagonists

   

(3as)-6-hydroxy-1-(1h-indol-3-yl)-3ah,4h-naphtho[2,1-b]furan-2,5-dione

(3as)-6-hydroxy-1-(1h-indol-3-yl)-3ah,4h-naphtho[2,1-b]furan-2,5-dione

C20H13NO4 (331.08445380000006)